The Combination Of Cdk4 And Mapk/Erk Pathway Inhibitor Therapy In Melanoma: Defining Melanoma Cell Intrinsic And Immune Mediated Responses

Grant number: 1100189 | Funding period: 2016 - 2019

Completed